Aldara activates TLR7-independent immune defence (Q28286677)

10

object named as

Sabine Werner

0 references

Alexander Knuth

12

object named as

Alexander Knuth

0 references

author name string

Anne Walter

1

0 references

Matthias Schäfer

2

0 references

Virginia Cecconi

3

0 references

Claudia Matter

4

0 references

Mirjana Urosevic-Maiwald

5

0 references

Benedetta Belloni

6

0 references

Nicola Schönewolf

7

0 references

Wilhelm Bloch

9

0 references

Hans-Dietmar Beer

11

0 references

Maries van den Broek

Imiquimod: in superficial basal cell carcinoma

13

0 references

language of work or name

English

0 references

publication date

2013

0 references

published in

Nature Communications

0 references

volume

4

0 references

page(s)

1560

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Imiquimod in basal cell carcinoma: how does it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Imiquimod enhances IFN-gamma production and effector function of T cells infiltrating human squamous cell carcinomas of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Cancer-testis antigens and immunosurveillance in human cutaneous squamous cell and basal cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Expression of Fas-receptor on basal cell carcinomas after treatment with imiquimod 5% cream or vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Imiquimod: mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Paracrine regulation of keratinocyte proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Keratinocyte-fibroblast interactions in wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

S100A8 and S100A9 in inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Interleukin-1, inflammasomes and the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Caspase-1-induced pyroptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Active caspase-1 is a regulator of unconventional protein secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Immune defence in mice lacking type I and/or type II interferon receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation

21 January 2018

1 reference

12 December 2020

Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts

1 reference

12 December 2020

Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice

1 reference

12 December 2020

Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression.

1 reference

12 December 2020

Granulocyte-macrophage colony-stimulating factor in psoriasis

1 reference

12 December 2020

c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin

1 reference

12 December 2020

The IL-1 family: regulators of immunity

1 reference

12 December 2020

Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor

1 reference

12 December 2020

Imiquimod, a topical immune response modifier, induces migration of Langerhans cells

1 reference

12 December 2020

Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9.

1 reference

12 December 2020

Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9

1 reference

12 December 2020

Imiquimod 5 percent cream and the treatment of cutaneous malignancy

1 reference

12 December 2020

Advances in the use of topical imiquimod to treat dermatologic disorders

1 reference

12 December 2020

The primary histologic lesion of seborrheic dermatitis and psoriasis

1 reference

12 December 2020

The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes

1 reference

12 December 2020

An ICAM-1 like cell adhesion molecule is responsible for CD34 positive haemopoietic stem cells adhesion to bone-marrow stroma

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS2566

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NCOMMS2566

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1381634

ADS bibcode

2013NatCo...4.1560W

0 references

1007297261

0 references

1381634

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference